ClinicalTrials.Veeva

Menu
D

Denver Public Health

Research site

Site insights

Top conditions

Top treatments

Lenacapavir
Darunavir
Raltegravir
MP0420
HIVID
Islatravir
PF-07304814
Maraviroc
Saquinavir
Ribavirin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Amanda Breeden

Verified by this site

Active trials

2 of 29 total trials

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologicall...

Active, not recruiting
HIV-1 Infection
Drug: ISL/LEN FDC
Drug: B/F/TAF

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose c...

Active, not recruiting
HIV-1-infection
Drug: B/F/TAF
Drug: Placebo to match B/F/TAF

Trial sponsors

National Institute of Allergy and Infectious Diseases (NIAID) logo
Gilead Sciences logo
Roche logo
A
E
GlaxoSmithKline (GSK) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems